Firm record

Asahi Kasei Life Science Corp.

◇Private·Japan·GICS Pharmaceuticals, Biotechnology and Life Sciences

This is a partial record assembled from open public datasets (WBA, Net Zero Tracker, SBTi, TPI, CDP). Reverberate's deeper extraction layer covers a curated cohort of firms — see the full directory for firms with verified financial + multi-year disclosure depth.

Partial profile

We haven't fully researched Asahi Kasei Life Science Corp. yet.

Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.

We’ll only use your email to notify you about this request.

Targets & commitments3

Source	Type	Scope	Base	Target year	Value	Status
sbti	near_term	3	2023	2030	60%	—
sbti	near_term	3	2023	2030	25%	—
sbti	near_term	Scope 1 + 2	2023	2030	42%	1.5°C

Identifiers

sbti_id	40021852
Reverberate ID	efd6e8fb…